Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
World Journal of Virology|August 18, 2015
Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?Tatsuo Kanda, Shingo Nakamoto, Osamu Yokosuka
International Journal of Molecular Sciences|July 9, 2022
Hepatitis A Virus Infection and Molecular ResearchTatsuo Kanda, Reina Sasaki-Tanaka, Shingo Nakamoto
World Journal of Hepatology|June 9, 2015
Antiviral therapies for chronic hepatitis C virus infection with cirrhosisShingo Nakamoto, Tatsuo Kanda, Hiroshi Shirasawa, et al.
Therapeutics and Clinical Risk Management|June 13, 2014
New treatments for genotype 1 chronic hepatitis C - focus on simeprevirTatsuo Kanda, Shingo Nakamoto, Shuang Wu, et al.
World Journal of Gastroenterology|January 1, 2014
Hepatitis C virus protease inhibitor-resistance mutations: our experience and reviewShuang Wu, Tatsuo Kanda, Shingo Nakamoto, et al.
Anticancer Research|September 21, 2012
Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cellsShuang Wu, Tatsuo Kanda, Shingo Nakamoto, et al.
World Journal of Gastroenterology|March 25, 2014
Hepatitis C virus NS5A inhibitors and drug resistance mutationsShingo Nakamoto, Tatsuo Kanda, Shuang Wu, et al.
World Journal of Gastroenterology|July 29, 2016
Hepatitis C virus genotypes in MyanmarNan Nwe Win, Tatsuo Kanda, Shingo Nakamoto, et al.
Experimental Cell Research|March 4, 2014
Involvement of androgen receptor and glucose-regulated protein 78 kDa in human hepatocarcinogenesisXia Jiang, Tatsuo Kanda, Shingo Nakamoto, et al.
International Journal of Medical Sciences|June 27, 2013
Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatmentMasato Nakamura, Tatsuo Kanda, Tatsuo Miyamura, et al.
Pageof 16